Pharmaceutical Manufacturing Market Growth Opportunities and Forecast till 2030
CHAPTER 1. Industry Overview of Pharmaceutical Manufacturing Market
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical Manufacturing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Manufacturing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Manufacturing Market By Formulation
1.2.3. Pharmaceutical Manufacturing Market By Route of Administration
1.2.4. Pharmaceutical Manufacturing Market By Prescription
1.2.5. Pharmaceutical Manufacturing Market By Drug Development
1.2.6. Pharmaceutical Manufacturing Market By Distribution Channel
1.2.7. Pharmaceutical Manufacturing Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Manufacturing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Manufacturing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Pharmaceutical Manufacturing Market By Formulation
5.1. Introduction
5.2. Pharmaceutical Manufacturing Market Revenue (USD Billion) By Formulation
5.2.1. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
5.2.2. Tablets
5.2.2.1. Tablets Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Injectable
5.2.3.1. Injectable Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Capsules
5.2.4.1. Capsules Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Sprays Suspensions
5.2.5.1. Sprays Suspensions Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Powders
5.2.6.1. Powders Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Pharmaceutical Manufacturing Market By Route of Administration
6.1. Introduction
6.2. Pharmaceutical Manufacturing Market Revenue (USD Billion) By Route of Administration
6.2.1. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
6.2.2. Oral
6.2.2.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Topical
6.2.3.1. Topical Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Parenteral
6.2.4.1. Parenteral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Inhalations
6.2.5.1. Inhalations Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Pharmaceutical Manufacturing Market By Prescription
7.1. Introduction
7.2. Pharmaceutical Manufacturing Market Revenue (USD Billion) By Prescription
7.2.1. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
7.2.2. Prescription Medicines
7.2.2.1. Prescription Medicines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Over-the-counter (OTC) Medicines
7.2.3.1. Over-the-counter (OTC) Medicines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. Pharmaceutical Manufacturing Market By Route of Administration
8.1. Introduction
8.2. Pharmaceutical Manufacturing Market Revenue (USD Billion) By Route of Administration
8.2.1. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
8.2.2. Outsource
8.2.2.1. Outsource Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. In-house
8.2.3.1. In-house Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. Pharmaceutical Manufacturing Market By Distribution Channel
9.1. Introduction
9.2. Pharmaceutical Manufacturing Market Revenue (USD Billion) By Distribution Channel
9.2.1. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.2.2. Online
9.2.2.1. Online Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.3. Offline
9.2.3.1. Offline Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 10. North America Pharmaceutical Manufacturing Market By Country
10.1. North America Pharmaceutical Manufacturing Market Overview
10.2. U.S.
10.2.1. U.S. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
10.2.2. U.S. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.2.3. U.S. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
10.2.4. U.S. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
10.2.5. U.S. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.3. Canada
10.3.1. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
10.3.2. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.3.3. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
10.3.4. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
10.3.5. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.4. North America PEST Analysis
CHAPTER 11. Europe Pharmaceutical Manufacturing Market By Country
11.1. Europe Pharmaceutical Manufacturing Market Overview
11.2. U.K.
11.2.1. U.K. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
11.2.2. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.2.3. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
11.2.4. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
11.2.5. U.K. Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.3. Germany
11.3.1. Germany Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
11.3.2. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.3.3. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
11.3.4. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
11.3.5. Germany Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.4. France
11.4.1. France Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
11.4.2. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.4.3. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
11.4.4. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
11.4.5. France Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.5. Spain
11.5.1. Spain Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
11.5.2. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.5.3. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
11.5.4. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
11.5.5. Spain Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.6. Rest of Europe
11.6.1. Rest of Europe Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
11.6.2. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.6.3. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
11.6.4. Canada Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
11.6.5. Rest of Europe Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.7. Europe PEST Analysis
CHAPTER 12. Asia Pacific Pharmaceutical Manufacturing Market By Country
12.1. Asia Pacific Pharmaceutical Manufacturing Market Overview
12.2. China
12.2.1. China Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
12.2.2. China Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.2.3. China Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
12.2.4. China Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
12.2.5. China Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.3. Japan
12.3.1. Japan Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
12.3.2. Japan Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.3.3. Japan Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
12.3.4. Japan Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
12.3.5. Japan Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.4. India
12.4.1. India Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
12.4.2. India Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.4.3. India Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
12.4.4. India Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
12.4.5. India Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.5. Australia
12.5.1. Australia Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
12.5.2. Australia Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.5.3. Australia Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
12.5.4. Australia Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
12.5.5. Australia Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.6. South Korea
12.6.1. South Korea Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
12.6.2. South Korea Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.6.3. South Korea Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
12.6.4. South Korea Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
12.6.5. South Korea Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.7. Rest of Asia-Pacific
12.7.1. Rest of Asia-Pacific Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
12.7.2. Rest of Asia-Pacific Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.7.3. Rest of Asia-Pacific Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
12.7.4. Rest of Asia-Pacific Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
12.7.5. Rest of Asia-Pacific Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.8. Asia Pacific PEST Analysis
CHAPTER 13. Latin America Pharmaceutical Manufacturing Market By Country
13.1. Latin America Pharmaceutical Manufacturing Market Overview
13.2. Brazil
13.2.1. Brazil Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
13.2.2. Brazil Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.2.3. Brazil Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
13.2.4. Brazil Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
13.2.5. Brazil Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.3. Mexico
13.3.1. Mexico Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
13.3.2. Mexico Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.3.3. Mexico Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
13.3.4. Mexico Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
13.3.5. Mexico Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.4. Rest of Latin America
13.4.1. Rest of Latin America Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
13.4.2. Rest of Latin America Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.4.3. Rest of Latin America Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
13.4.4. Rest of Latin America Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
13.4.5. Rest of Latin America Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.5. Latin America PEST Analysis
CHAPTER 14. Middle East & Africa Pharmaceutical Manufacturing Market By Country
14.1. Middle East & Africa Pharmaceutical Manufacturing Market Overview
14.2. GCC
14.2.1. GCC Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
14.2.2. GCC Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.2.3. GCC Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
14.2.4. GCC Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
14.2.5. GCC Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.3. South Africa
14.3.1. South Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
14.3.2. South Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.3.3. South Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
14.3.4. South Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
14.3.5. South Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.4. Rest of Middle East & Africa
14.4.1. Rest of Middle East & Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Formulation, 2018-2030
14.4.2. Rest of Middle East & Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.4.3. Rest of Middle East & Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Prescription, 2018-2030
14.4.4. Rest of Middle East & Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Drug Development, 2018-2030
14.4.5. Rest of Middle East & Africa Pharmaceutical Manufacturing Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.5. Middle East & Africa PEST Analysis
CHAPTER 15. Player Analysis Of Pharmaceutical Manufacturing Market
15.1. Pharmaceutical Manufacturing Company Share Analysis
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
15.2.2. Formulation Launches and Formulation Enhancements
15.2.3. Mergers And Acquisition In Global Pharmaceutical Manufacturing market
15.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 16. Company Profile
16.1. AstraZeneca
16.1.1. Company Snapshot
16.1.2. Business Overview
16.1.3. Financial Overview
16.1.3.1. Revenue (USD Billion), 2021
16.1.3.2. AstraZeneca 2021 Pharmaceutical Manufacturing Business Regional Distribution
16.1.4. Formulation/ Service and Specification
16.1.5. Recent Developments & Business Strategy
16.1.6. Manufacturing Plant Footprint Analysis
16.2. Eli Lilly and Company
16.3. F. Hoffmann-La Roche Ltd.
16.4. GlaxoSmithKline plc
16.5. Johnson & Johnson
16.6. Lonza
16.7. Merck & Co. Inc.
16.8. Novartis AG
16.9. Pfizer, Inc.
16.10. Sanofi SA